Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct 29;11(11):1276.
doi: 10.3390/genes11111276.

DNA Associated with Circulating Exosomes as a Biomarker for Glioma

Manjusha Vaidya  1 , Kiminobu Sugaya  1
Affiliations
Review

DNA Associated with Circulating Exosomes as a Biomarker for Glioma

Manjusha Vaidya et al. Genes (Basel). .

Abstract

Cancerous and non-cancerous cells secrete exosomes, a type of nanovesicle known to carry the molecular signature of the parent for intercellular communications. Exosomes secreted by tumor cells carry abnormal DNA, RNA, and protein molecules that reflect the cancerous status. DNA is the master molecule that ultimately affects the function of RNA and proteins. Aberrations in DNA can potentially lead a cell to malignancy. Deviant quantities and the differential sequences of exosomal DNA are useful characteristics as cancer biomarkers. Since these alterations are either associated with specific stages of cancer or caused due to a clinical treatment, exosomal DNA is valuable as a diagnostic, prognostic, predictive, and therapeutic-intervention response biomarker. Notably, the exosomes can cross an intact blood-brain barrier and anatomical compartments by transcytosis. As such, the cancer-specific trademark molecules can be detected in systemic blood circulation and other body fluids, including cerebrospinal fluid, with non-invasive or minimally invasive procedures. This comprehensive review highlights the cancer-specific modulations of DNA associated with circulating exosomes that are beneficial as glioma biomarkers.

Keywords: biomarkers; cancer stem cells; cell-free DNA; exosomes; oncogenes; stemness genes.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to declare.

Figures

Figure 1
Figure 1
Exosomal DNA as brain cancer biomarkers. The selection of body fluids, the types of DNA and the analyses performed with the exosomal DNA to establish them as prognostic, diagnostic or therapy response biomarkers for the brain cancers.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. National Cancer Institute. [(accessed on 5 May 2020)]; Available online: https://www.cancer.gov/about-cancer/understanding/what-is-cancer.
    1. Toschi L., Finocchiaro G., Nguyen T.T., Skokan M.C., Giordano L., Gianoncelli L., Perrino M., Siracusano L., Di Tommaso L., Infante M., et al. Increased SOX2 Gene Copy Number Is Associated with FGFR1 and PIK3CA Gene Gain in Non-Small Cell Lung Cancer and Predicts Improved Survival in Early Stage Disease. PLoS ONE. 2014;9:e95303. doi: 10.1371/journal.pone.0095303. - DOI - PMC - PubMed
    1. García-Romero N., Carrión-Navarro J., Esteban-Rubio S., Lázaro-Ibáñez E., Peris-Celda M., Alonso M.M., Guzmán-De-Villoria J., Fernández-Carballal C., De Mendivil A.O., García-Duque S., et al. DNA sequences within glioma-derived extracellular vesicles can cross the intact blood-brain barrier and be detected in peripheral blood of patients. Oncotarget. 2016;8:1416–1428. doi: 10.18632/oncotarget.13635. - DOI - PMC - PubMed
    1. Wu M., Wang G., Hu W., Yao Y., Yu X.-F. Emerging roles and therapeutic value of exosomes in cancer metastasis. Mol. Cancer. 2019;18:1–11. doi: 10.1186/s12943-019-0964-8. - DOI - PMC - PubMed
    1. Ciregia F., Urbani A., Palmisano G. Extracellular Vesicles in Brain Tumors and Neurodegenerative Diseases. Front. Mol. Neurosci. 2017;10:276. doi: 10.3389/fnmol.2017.00276. - DOI - PMC - PubMed

Publication types